The gastrointestinal peptide glucagon-like peptide 1 (GLP-1) is known to regulate consummatory behavior and is released in response to nutrient ingestion. Analogues of this peptide recently emerged as novel pharmacotherapies for treatment of type II diabetes since they reduce gastric emptying. glucagon secretion as well as enhance glucose-dependent insulin secretion. The findings that... https://www.hindigyanvishv.com/